How Tirzepatide and Semaglutide Fit Into GLP-1 Microdosing Both tirzepatide and semaglutide belong to the incretin therapy class
Mounjaro (tirzepatide) is a new, injectable medication indicated for use in patients with type 2 diabetes
Roberto Amado, MD, MHA , prescribes oral semaglutide for eligible patients as part of a holistic weight management program that includes dietary counseling, exercise recommendations, and ongoing health monitoring
For example, in the SELECT trial, participants maintained a mean weight reduction of around 10.2% after 208 weeks of treatment, significantly outperforming those on placebo
Such symptoms may reflect your body's adjustment to rapid weight loss, electrolyte shifts, or increased physical activitynot conditions requiring ongoing NSAID use